PIK3CA and cancer: Cancer with activated PI3K/AKT signaling has been demonstrated to present as an aggressive phenotype, and the activation of PI3K/AKT signaling has been indicated as a significant risk factor for early recurrence and poor prognosis in liver cancer patients [8,9,10].